TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Eclipse Biofarm AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,259
|
1,447
|
1,517 |
| Financial expenses |
20
|
18
|
6 |
| Earnings before taxes |
-20
|
13
|
90 |
| EBITDA |
30
|
54
|
117 |
| Total assets |
880
|
884
|
1,047 |
| Current assets |
679
|
666
|
872 |
| Current liabilities |
553
|
524
|
701 |
| Equity capital |
310
|
337
|
326 |
| - share capital |
17
|
18
|
18 |
| Employees (average) |
5
|
6
|
8 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.2%
|
38.1%
|
31.1% |
| Turnover per employee |
252
|
241
|
190 |
| Profit as a percentage of turnover |
-1.6%
|
0.9%
|
5.9% |
| Return on assets (ROA) |
0%
|
3.5%
|
9.2% |
| Current ratio |
122.8%
|
127.1%
|
124.4% |
| Return on equity (ROE) |
-6.5%
|
3.9%
|
27.6% |
| Change turnover |
-139
|
-74
|
128 |
| Change turnover % |
-10%
|
-5%
|
9% |
| Chg. No. of employees |
-1
|
-2
|
3 |
| Chg. No. of employees % |
-17%
|
-25%
|
60% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.